Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor: A novel treatment option for nurse practitioners treating patients with psoriatic disease. [electronic resource]
Producer: 20170417Description: 683-695 p. digitalISSN:- 2327-6924
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.